Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of NKTR by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−14,380−100.0%Sold outHolders
Q2 202514,380$371.5K<0.1%−10,530−42.3%ReducedConverted for a 1-for-15 splitHolders
Q1 2025373,654$254.5K<0.1%−119,985−24.3%ReducedHolders
Q4 2024493,639$459.2K<0.1%−10,585−2.1%ReducedHolders
Q3 2024504,224$654.5K<0.1%−11,774−2.3%ReducedHolders
Q2 2024515,998$639.1K<0.1%−27,764−5.1%ReducedHolders
Q1 2024543,762$508.0K<0.1%−2,903−0.5%ReducedHolders
Q4 2023546,665$308.8K<0.1%−41,324−7.0%ReducedHolders
Q3 2023587,989$350.3K<0.1%−221,060−27.3%ReducedHolders
Q2 2023809,049$465.4K<0.1%−1,275,412−61.2%ReducedHolders
Q1 20232,084,461$1.46M<0.1%−465,588−18.3%ReducedHolders
Q4 20222,550,049$5.76M<0.1%+1,297,677+103.6%AddedHolders
Q3 20221,252,372$4.01M<0.1%−436,597−25.8%ReducedHolders
Q2 20221,688,969$6.42M<0.1%−313,632−15.7%ReducedHolders
Q1 20222,002,601$10.8M<0.1%+451,433+29.1%AddedHolders
Q4 20211,551,168$21.0M<0.1%+286,155+22.6%AddedHolders
Q3 20211,265,013$22.7M<0.1%−344,619−21.4%ReducedHolders
Q2 20211,609,632$27.6M<0.1%+657,701+69.1%AddedHolders
Q1 2021951,931$19.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.